POLIOVIRUS VACCINE, INACTIVATED (IPOL, POLIOVAX)

Course overview

Inactivated poliovirus vaccine (IPV) is U.S. FDA-approved to prevent acute poliomyelitis in adults and children ≥ 6 weeks. This continuing education module is designed to give the reader/learner an increased understanding of inactivated poliovirus vaccine. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.